First FDA-approved gene therapy for rare immune disorder offers new hope for children
01 April 2026
A new gene therapy has received approval from the U.S. Food and Drug Administration, marking the first approved treatment for the rare genetic immune disorder Leukocyte Adhesion Deficiency Type I (LAD-I)… Read More…









